Full video transcriptClick to expand
Auto-generated transcript of @zdopingowani's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00He's perhaps the intention.
- 0:01However, he's not helping me to do very well with this,
- 0:04because I can't believe that he's a big boy,
- 0:05and that this is a big thing,
- 0:07and he's not a big boy or a big boy.
- 0:08He's starting to laugh,
- 0:10he's starting to laugh,
- 0:11he's starting to laugh and he gets to laugh,
- 0:13he's starting to laugh on each other.
- 0:17As for this, he's still trying to make me laugh,
- 0:20but he's also trying to be a little bit more wherous,
- 0:23and that was the worst thing of what happened to me.
- 0:26I'm not gonna do that.
- 0:58We are now going to the next stage,
- 1:01to take the next stage,
- 1:03and we'll be working on the next stage,
- 1:06while we are all looking forward to a bit of the production.
- 1:08So, let's start.
- 1:09I'll start with the last stage.
- 1:11The first stage,
- 1:14is a really good stage,
- 1:16and I'll also get the last stage,
- 1:19and the first stage,
- 1:21is the first stage,
- 1:23which is the first stage that we're going to do.
- 1:25And, the second stage,
- 1:26In the past, we've been able to do the best we can to improve our productivity.
- 1:33We've been able to do the same thing in order to improve our productivity.
- 1:40We've been able to do a lot in our social media,
- 1:43so we're not able to do it anymore.
- 1:46We were able to do the same thing and we created a large strategy.
- 1:51This is what affects the world's lives.
- 1:56And we have a lot of stories.
- 2:00Sometimes it's terrible to talk about,
- 2:02but we don't have a problem with it,
- 2:05so that the world doesn't have a lot of meaning.
- 2:09I think it's difficult to talk about the health of the world.
- 2:13We have a lot of meaning,
- 2:14to ensure that we have a lot of meaning.
- 2:17This is the first time I've worked with the first one.
- 2:22We have been doing a few years ago,
- 2:24and I haven't seen it before,
- 2:27but I've been doing it for a long time.
- 2:30It's not just for me,
- 2:32I don't think that's the only thing I can do,
- 2:34but I have to work with them.
- 2:36I think it's better to know that I have a particular practice
- 2:40because when I have a lot of problems,
- 2:43I've been thinking about it.
- 2:44I'm going to make a video about the product that I use in order to make a video.
- 2:51I'm going to show you how to make a video.
- 2:56I'm going to show you how to make a video.
Kisspeptin-10 for fertility and testosterone: what the evidence says
Quick answer
Kisspeptin-10 is the shortest biologically active fragment of the KISS1-derived peptide family, acting as a potent GnRH secretagogue with established roles in reproductive neuroendocrinology. The video, framed around TRT recovery and fertility, appears to position it within post-cycle hormonal restart protocols, an application that has theoretical mechanistic support but lacks validated human trial data in the relevant population. Clinical research to date has focused on pharmaceutical-grade infusion in hypogonadotropic hypogonadism, not subcutaneous self-administration in androgen-suppressed athletes.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Kisspeptin-10 for fertility and testosterone: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With HSDD: A Randomized Clinical Trial
Double-blind placebo-controlled crossover in 32 men where kisspeptin modulated sexual brain networks and increased penile tumescence versus placebo.
PubMed
Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
Double-masked placebo-controlled crossover in 32 premenopausal women showing kisspeptin modulated sexual and attraction brain processing.
PubMed
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Kisspeptin-10 for fertility and testosterone: what the evidence says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Kisspeptin-10 for fertility and testosterone: what the evidence says" from Michał Podejko. We read the clip as a Peptide social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Kisspeptin-10 is the shortest biologically active fragment of the KISS1-derived peptide family, acting as a potent GnRH secretagogue with established roles in reproductive neuroendocrinology.
The reason this review is not generic is the source wording and the canonical claim label "peptides kisspeptin 10 opis peptydu jego zastosowanie i efekty uboczn." In this clip, the useful excerpt is: "He's perhaps the intention." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With HSDD: A Randomized Clinical Trial (2023), Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial (2022), and Direct comparison of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men (2015), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Kisspeptin-10 is the shortest biologically active fragment of the KISS1-derived peptide family, acting as a potent GnRH secretagogue with established roles in reproductive neuroendocrinology.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Kisspeptin-10 is the shortest biologically active fragment of the KISS1-derived peptide family, acting as a potent GnRH secretagogue with established roles in reproductive neuroendocrinology. The video, framed around TRT recovery and fertility, appears to position it within post-cycle hormonal restart protocols, an application that has theoretical mechanistic support but lacks validated human trial data in the relevant population. Clinical research to date has focused on pharmaceutical-grade infusion in hypogonadotropic hypogonadism, not subcutaneous self-administration in androgen-suppressed athletes.
- Kisspeptin is a legitimate neuropeptide: its role as a GnRH secretagogue is supported by over two decades of peer-reviewed research (Skorupskaite et al., 2014, Human Reproduction Update).
- Clinical studies on kisspeptin-54 and kisspeptin-10 have used intravenous or subcutaneous infusion under controlled conditions, not the self-administered vial protocols circulating in peptide communities.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Kisspeptin is a legitimate neuropeptide: its role as a GnRH secretagogue is supported by over two decades of peer-reviewed research (Skorupskaite et al., 2014, Human Reproduction Update).
- Clinical studies on kisspeptin-54 and kisspeptin-10 have used intravenous or subcutaneous infusion under controlled conditions, not the self-administered vial protocols circulating in peptide communities.
- Kisspeptin-10 has a plasma half-life of approximately two to four minutes in humans, making consistent hormonal stimulation through casual self-injection pharmacologically difficult.
- Fertility benefits have been documented specifically in men with hypogonadotropic hypogonadism (Jayasena et al., 2014, Clinical Endocrinology), not in otherwise healthy men recovering from anabolic steroid use.
- Gray-market kisspeptin-10 products carry no purity guarantees; contaminants and inaccurate dosing are documented risks across the unregulated research chemical supply chain.
- HCG remains the evidence-backed standard for LH-axis stimulation in post-cycle recovery contexts; substituting or stacking kisspeptin-10 without medical supervision is speculative and potentially counterproductive.
- If fertility or testosterone recovery is a genuine medical concern, a reproductive endocrinologist or urologist can offer regulated, evidence-supported options that a TikTok peptide video cannot.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @zdopingowani actually say?
Honestly, this is a tough one to fact-check. The transcript provided for this video is almost entirely incoherent, likely the result of a failed auto-transcription of Polish-language audio. What we can work with is the video's caption, which describes kisspeptin-10, its applications, and its side effects, along with hashtags pointing to TRT, fertility, testosterone, and post-cycle recovery ("odblok"). Based on that framing, this video appears to be explaining kisspeptin-10 as a tool for hormonal optimization, possibly as an alternative or complement to HCG in testosterone recovery protocols. We can't quote the creator directly because the transcript is gibberish. So this fact-check is built on what the caption signals and what the peptide community typically claims about kisspeptin-10.
Does the science back this up?
The short answer: kisspeptin is real, its biology is well-established, but clinical use in the form sold in peptide markets is nowhere near proven. Kisspeptin is a neuropeptide encoded by the KISS1 gene that acts on GnRH neurons in the hypothalamus, triggering downstream release of LH and FSH. That mechanism is not in dispute.
Research by Dhillo et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that intravenous kisspeptin-54 robustly stimulated LH release in healthy men. Later work by Jayasena et al. (2014, Clinical Endocrinology) showed that kisspeptin-54 could stimulate sperm parameters in men with hypogonadotropic hypogonadism. The shorter fragment, kisspeptin-10, has similar receptor affinity in vitro but a much shorter half-life in vivo, which is a practical problem that peptide sellers rarely mention.
The jump from "kisspeptin works in a hospital infusion study" to "kisspeptin-10 vials from a research chemical supplier will restore your testosterone" is a large one. Bioavailability, dosing frequency, and product purity are all unresolved in real-world use.
What did they get wrong (or right)?
Without a clean transcript, we can't pin specific errors on the creator. But the hashtag framing tells a story. Pairing kisspeptin with "odblok" (post-cycle recovery), HCG, and TRT suggests the video is positioning this peptide as part of a HPTA restart protocol. That framing is popular in bodybuilding communities and it is not entirely without logic, because kisspeptin does sit upstream of the HPG axis. But here is where things go sideways.
- Kisspeptin-10 has a plasma half-life of roughly two to four minutes in humans, making subcutaneous self-administration a pharmacokinetically awkward choice compared to protocols studied in clinical settings.
- No randomized controlled trial has validated a kisspeptin-10 subcutaneous protocol for post-anabolic steroid recovery in otherwise healthy men. The fertility data is in men with documented hypogonadotropic hypogonadism, not suppressed-but-otherwise-healthy bodybuilders.
- HCG, which the hashtags also reference, acts directly on Leydig cells and has decades of clinical data. Treating kisspeptin-10 as equivalent or superior is speculative at this stage.
If the video gave credit to kisspeptin's legitimate role in reproductive endocrinology research, that part is fair. If it implied this is a proven, safe self-administration protocol, that part is not.
What should you actually know?
Kisspeptin is genuinely interesting science. It is not pseudoscience. But interesting science in a research context and "peptide you should inject for your post-cycle therapy" are two different things, and the gap between them matters for your health.
The peptide sold as kisspeptin-10 in gray-market research chemical stores has no guaranteed purity, no standardized dosing protocol supported by human trials, and no regulatory approval anywhere for the uses being described. The studies worth reading, including Skorupskaite et al. (2014, Human Reproduction Update), focus on endogenous kisspeptin signaling and pharmaceutical-grade infusion protocols, not self-administered vials.
If you are dealing with post-TRT suppression or fertility concerns, a reproductive endocrinologist can offer clomiphene, HCG, or FSH protocols with actual clinical evidence behind them. Kisspeptin-10 may eventually join that toolkit. Right now, it is not there yet. Treating a TikTok video as a protocol guide for hormonal recovery is a risk that the algorithm will not share with you.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Michał Podejko · TikTok creator
29.3K views on this video
kisspeptin 10 opis peptydu jego zastosowanie i efekty uboczne #wiedza #trt #plodnosc #peptydy #zdrowie #odblok #hcg #testoseron
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about kisspeptin?
Kisspeptin is a legitimate neuropeptide: its role as a GnRH secretagogue is supported by over two decades of peer-reviewed research (Skorupskaite et al., 2014, Human Reproduction Update).
What does the video say about clinical studies on kisspeptin-54?
Clinical studies on kisspeptin-54 and kisspeptin-10 have used intravenous or subcutaneous infusion under controlled conditions, not the self-administered vial protocols circulating in peptide communities.
What does the video say about kisspeptin-10 has a plasma half-life of approximately two to four?
Kisspeptin-10 has a plasma half-life of approximately two to four minutes in humans, making consistent hormonal stimulation through casual self-injection pharmacologically difficult.
What does the video say about fertility benefits have been documented specifically in men with hypogonadotropic?
Fertility benefits have been documented specifically in men with hypogonadotropic hypogonadism (Jayasena et al., 2014, Clinical Endocrinology), not in otherwise healthy men recovering from anabolic steroid use.
What does the video say about gray-market kisspeptin-10 products carry no purity guarantees; contaminants?
Gray-market kisspeptin-10 products carry no purity guarantees; contaminants and inaccurate dosing are documented risks across the unregulated research chemical supply chain.
What does the video say about hcg remains the evidence-backed standard for lh-axis stimulation in post-cycle?
HCG remains the evidence-backed standard for LH-axis stimulation in post-cycle recovery contexts; substituting or stacking kisspeptin-10 without medical supervision is speculative and potentially counterproductive.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Michał Podejko, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.